Literature DB >> 26077574

Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata.

Yu-Mei Han1, You-Yu Sheng1, Feng Xu1, Si-Si Qi1, Xiao-Jing Liu1, Rui-Ming Hu1, Ying Miao1, Gui-Qin Huang1, Qin-Ping Yang1.   

Abstract

There is mounting evidence that T helper (Th)17 cells and regulatory T cells (Treg) play parts in the pathogenesis of autoimmune disease. Hence, levels of these T-cell subsets in patients with alopecia areata (AA) merit investigation. Our goal was to assess Th17 and Treg levels in peripheral blood mononuclear cells (PBMC) and scalp lesions of patients with AA, correlating the findings with clinical characteristics. PBMC of 177 patients with AA (test group) and 42 healthy controls and scalp tissues of 33 patients and 15 healthy controls were collected. Levels of Th17 and Treg subsets were then determined via flow cytometry and immunohistochemical staining, correlating results in test subjects with clinical features of AA. Th17 levels were significantly higher in patients, whereas Treg levels were lower by comparison. Furthermore, Th17 levels in patients with disease of short duration or in the active phase were significantly higher, relative to their respective counterparts. Th17 levels also negatively correlated with disease duration. While Treg levels were higher in severe AA than in mild AA. Results of lesions were parallel to findings of PBMC. Our data indicates an imbalance in the immune state of patients with AA.
© 2015 Japanese Dermatological Association.

Entities:  

Keywords:  Foxp3; T-helper cell 17; alopecia areata; interleukin-17; regulatory T cells

Mesh:

Substances:

Year:  2015        PMID: 26077574     DOI: 10.1111/1346-8138.12978

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  21 in total

Review 1.  Regulatory T cells in skin.

Authors:  Niwa Ali; Michael D Rosenblum
Journal:  Immunology       Date:  2017-08-04       Impact factor: 7.397

Review 2.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

Review 3.  Vitamin D and alopecia areata: possible roles in pathogenesis and potential implications for therapy.

Authors:  Xiran Lin; Xianmin Meng; Zhiqi Song
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

4.  The Immunogenetics of Alopecia areata.

Authors:  Fateme Rajabi; Fahimeh Abdollahimajd; Navid Jabalameli; Mansour Nassiri Kashani; Alireza Firooz
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 5.  Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.

Authors:  Cheng Zhou; Xiangqian Li; Chen Wang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-17       Impact factor: 8.667

Review 6.  The current state of knowledge of the immune ecosystem in alopecia areata.

Authors:  Samuel J Connell; Ali Jabbari
Journal:  Autoimmun Rev       Date:  2022-02-10       Impact factor: 17.390

Review 7.  Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.

Authors:  Amos Gilhar; Adam G Schrum; Amos Etzioni; Herman Waldmann; Ralf Paus
Journal:  Autoimmun Rev       Date:  2016-03-10       Impact factor: 9.754

Review 8.  Human αβ and γδ T Cells in Skin Immunity and Disease.

Authors:  Michelle S Cruz; Alani Diamond; Astrid Russell; Julie Marie Jameson
Journal:  Front Immunol       Date:  2018-06-06       Impact factor: 7.561

Review 9.  Cellular human tissue-engineered skin substitutes investigated for deep and difficult to heal injuries.

Authors:  Álvaro Sierra-Sánchez; Kevin H Kim; Gonzalo Blasco-Morente; Salvador Arias-Santiago
Journal:  NPJ Regen Med       Date:  2021-06-17

Review 10.  Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes.

Authors:  Minh N Pham; Matthias G von Herrath; Jose Luis Vela
Journal:  Front Immunol       Date:  2016-01-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.